In patients with nonMuSK+* generalized myasthenia gravis (gMG), early initiation of therapy with the B-cell–depleting monoclonal antibody rituximab may improve treatment outcomes compared with conventional immunosuppressant therapy**, a Swedish retrospective analysis has shown.
There is not enough evidence to support the claim that multiple sclerosis (MS) disease-modifying therapies (DMTs) increase the risk of infection with SARS-CoV-2, the virus that causes the novel coronavirus disease (COVID-19), suggests a recent review article.
New drug applications approved by US FDA as of 01 - 15 May 2020 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
A Chinese cross-sectional case-control study has identified time spent following news on coronavirus disease 2019 (COVID-19) and drug-resistant epilepsy as two independent predictors of severe psychological distress among epilepsy patients during the COVID-19 pandemic.
New drug applications approved by US FDA as of 16 - 30 April 2020 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
The use of capsule endoscopy (CE) appears to be effective in the diagnosis of iron deficiency anaemia (IDA), yielding a 33.9-percent yield in this study, with 65.8 percent of patients undergoing further workup and 12.7 percent requiring therapeutic intervention.
Eating behaviours have been shown to moderate the relationship between cumulated risk factors in the first 1,000 days and adiposity outcomes at 6 years of age, which underscores modifiable behavioural targets for interventions, reports a study.
Use of noninvasive ventilation (NIV), similar to invasive mechanical ventilation (IMV), appears to lessen mortality but may increase the risk for transmission of the novel coronavirus disease (COVID-19) in healthcare workers, suggest the results of a study.